Warner Chilcott Limited announced today that one of the Company's subsidiaries and Hospira, Inc. have received Paragraph IV Certification Notices from Mutual Pharmaceutical Company, Inc. and Mylan Pharmaceuticals Inc. advising that each such company has filed an Abbreviated New Drug Application (ANDA) for generic versions of DORYX 100 and 75 mg delayed-release tablets.
The details can be read here.
No comments:
Post a Comment